While Covid-19 research has dominated the headlines, day-to-day research into many other conditions to improve our understanding of the human body has also continued. Here are some of the breakthroughs achieved across Europe in 2020.
The essential role of animals in biomedical research was never clearer than in the momentous year of 2020. As the Covid-19 pandemic took hold, research involving animals played a critical role at the outset in helping researchers understand the virus itself, the mechanics of its transmission, and eventually the safety and efficiency of all the vaccines produced to bring the end of the pandemic a step closer.
To demonstrate this achievement, EARA produced a global interactive map to show what biomedical research was conducted using animal models in 2020, the species used and its location, across 24 different European countries.
In particular, research with ferrets, monkeys and genetically altered mice, allowed scientists to gain a greater understanding of how the virus was passed between individuals, and how it affected the cells of the body. At the University of Helsinki, dogs were trained to identify Covid-19 in humans using their sense of smell. The dogs are now being used as part of a pilot programme at some airports to detect infection in new arrivals.
Meanwhile, the search for alternative treatments involved other, larger animals including llamas and alpacas. Research conducted by EARA member Ghent University in Belgium in collaboration with the University of Texas and the National Institutes of Health, USA, showed that llama antibodies are effective in neutralising the coronavirus by preventing it from breaking through into host cells. This work has now moved to preclinical trials in monkeys and hamsters before entering human clinical trials.
Large mammals such as pigs and sheep have also been valuable in Covid-19 research, for the production and development of ventilators which have been essential for patients with severe Covid-19 infections.
Vaccine development was also reliant on animal testing, with all the approved vaccines tested for safety with mice and non-human primates in line with guidance from the European Medicines Agency.
“The rhesus macaque is pretty much the closest thing we have to humans,”
Dr. Vincent Munster, who led the primate research testing for the Oxford/AstraZeneca vaccine.
Meanwhile, work continued on vaccines for other deadly diseases that threaten large human populations. In June 2020, the World Health Organization announced that the world’s second-deadliest Ebola outbreak had been ended thanks to rollout of the first successful vaccine and two antibody drugs developed in monkeys. Research into development of a Zika vaccine is also improving, with two candidates undergoing trials in mice and monkeys.
Here are some other breakthroughs in biomedical research from around Europe this year.
Medical advances across Europe
Researchers at the Austrian Academy of Sciences (IMBA) have used fruit flies to understand how cancer cells generate energy to allow them to keep dividing to form a tumour. Through imaging researchers noticed that the metabolic changes in the fly cancer cells were due to changes in the mitochondria, which provide energy to the cell.
"Our findings overturn previous concepts about the biology of these tumours and open up an array of exciting follow up questions,”
said Jürgen Knoblich, IMBA group leader and scientific director.
Scientists from EARA member KU Leuven succeeded in growing bone tissue on a large scale. Based on studies with laboratory animals, including mice, the team produced bone tissue that could be grown through 3D bioprinting – a method used to fabricate biomedical parts that imitate natural tissue characteristics.
Research at Aarhus University has shown what happens to nanoparticles, tools that can be used to deliver drugs, in the bloodstream of a living organism. Using zebrafish embryos, the team traced the journey of nanoparticles travelling through the blood to their final destination in the cell.
A study in mice by EARA members the University of Helsinki, and the Max Planck Institute for Biology and Aging, Germany, has found how loss of a protein named Rictor can prevent hair regrowth.
Researchers at the University of Lille, have found a potential new strategy to improve the symptoms in Parkinson’s disease patients by creating an oxygen-free formulation of dopamine, which improves the motor skills of monkeys with the condition.
Scientists at the Ruhr University Bochum, have made paralysed mice walk again by stimulating healing in the spinal cord (video). Researchers used gene therapy to encourage cells to produce a protein which stimulated nerve cell growth in the damaged muscle, and found that mice were able to walk again within 2-3 weeks.
Researchers have studied hibernating bears to understand how they avoid muscle wasting. The findings from EARA member the Max Delbrück Center for Molecular Medicine (MDC), Berlin, could help prevent hospital patients, and astronauts, from suffering muscle atrophy, usually caused by a lack of physical activity.
Researchers at NYU Langone Health’s Neuroscience Institute, USA, and Instituto Italiano di Tecnologia and the University of Trento, have used animal studies to work out how the brain understands odours. The findings show that by activating a specific pattern of nerve endings in mice brains, they can make mice smell scents that don’t exist in the real world.
Scientists at the Netherlands Institute for Neuroscience (NIN), Amsterdam, have created a brain implant that could restore some vision in blind people by creating high-resolution implants which were inserted to the brains of two sighted monkeys. The results show that these implants make it possible to recognise artificially induced images.
EARA member Instituto Gulbenkian de Ciência has used a mouse model to help understand how immune cells known as T lymphocytes can lead to blood cancer when not properly developed. The team hope that understanding how the cells develop might lead to easier and earlier diagnosis of such cancers in the future.
Scientists at the CEDOC-NOVA Medical School, Lisbon, have found a therapy that could provide a way for patients to manage type 2 diabetes with fewer side-effects. The team found that is possible to improve insul